Found "Public health policy": 1,033 results
Sort by
Sort by
Z - A
A Tribute to Professor Sir Mike Rawlins: NICE Founding Chairman and the World Leader of Health and Social Care Guidance and Medicine Evaluation
In the death of Professor Sir Mike David Rawlins, founding chairman of the National Institute for Health and Care Excellent (NICE), who passed away at 81, the world of health and social care guidance and medicine evaluation community has lost one of its greatest leaders.
Over his
A Tribute to Dr. David Banta: the Pioneer of HTA
Since its inception, health technology assessment (HTA) has assisted governments across the world through evidence-informed health resources allocation and it all begins at the Office of Technology Assessment (OTA), United States Congress led by Dr. David Banta.This video is a tribute to Dr. David B
A Terrible Beauty: A Short History of NICE The National Institute of Health and Care Excellence
“A Terrible Beauty is a relatively short account of the origins and formation of NICE, originally the National Institute for Clinical Excellence, and of its first sixteen years of operations. Together with some assessment of its impact to date.”
– Nicholas Timmins –
A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines (2016)
Kittiphong Thiboonboon1 , Benjarin Santatiwongchai1 ,Varit Chantarastapornchit1 , Waranya Rattanavipapong1 , Yot Teerawattananon1
Abstract
Background
For more than three decades, the number and influence of economic evaluations of healthcare interventions have been increasing and gaining atte
A Systematic Review of Economic Evaluation Literature in Thailand. Are the Data Good Enough to be Used by Policy-Makers? (2007)
A Systematic Review of Economic Evaluation Literature in Thailand. Are the Data Good Enough to be Used by Policy-Makers?
Yot Teerawattananon1 Steve Russell2 Miranda Mugford3
1 International Health Policy Program, MInistry of Public Health, Nonthaburi, Thailand
2 School of Development Studie
A synthesis of policy recommendations on economic evaluation of biologic and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs) for the treatment of rheumatoid arthritis patients with high disease activity
โรคข้ออักเสบรูมาตอยด์ (rheumatoid arthritis หรือ RA) เป็นโรคข้ออักเสบชนิดไม่ทราบสาเหตุ (idiopathic inflammatory arthritis) ที่มีการอักเสบเรื้อรังของเยื่อหุ้มข้อ
A synthesis of policy recommendations on budgeting of implementing sofosbuvir/velpatasvir as a pan-genotypic regimen for the treatment of chronic hepatitis C in Thailand
63231002RM 023L0Chronic Hepatitis C,HCV,Hepatitis C Virus,sof/vel,sofosbuvir,velpatasvir,ไวรัสตับอักเสบซี
A Study Visit Report: Unpacking Thailand’s Medicine Pricing, Reimbursement Policy and Benefits Package
This report summarizes the sessions in the Medicines Pricing, Reimbursement Policy, and Benefits Package for Medicines in Thailand study visit, held on 4 – 8 March 2024 in Nonthaburi, Thailand. This study visit was organized by the Health Intervention and Technology Assessment Program (HITAP) under
A study to develop a quarantine guideline for medical and public health personnel who have been exposed to COVID-19
Project Consultant Dr. Yot Teerawattananon and Dr. Wanrudee Isaranuwatchai 63191002RM018L0quarantine guideline
10 / Page